IL6 and metabolic dysfunction-associated steatotic liver disease: TNF-α, IL-1β, IL-6, IL-10, and MCP-1 mRNA expression was significantly decreased in PA- and Orlistat-treated group as compared to their expression in the NAFLD group (Figure 4).